These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23623990)

  • 61. Sodium butyrate and mood stabilizers block ouabain-induced hyperlocomotion and increase BDNF, NGF and GDNF levels in brain of Wistar rats.
    Varela RB; Valvassori SS; Lopes-Borges J; Mariot E; Dal-Pont GC; Amboni RT; Bianchini G; Quevedo J
    J Psychiatr Res; 2015 Feb; 61():114-21. PubMed ID: 25467060
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Therapeutic effects of baicalein on rotenone-induced Parkinson's disease through protecting mitochondrial function and biogenesis.
    Zhang X; Du L; Zhang W; Yang Y; Zhou Q; Du G
    Sci Rep; 2017 Aug; 7(1):9968. PubMed ID: 28855526
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson's disease.
    Duan W; Ladenheim B; Cutler RG; Kruman II; Cadet JL; Mattson MP
    J Neurochem; 2002 Jan; 80(1):101-10. PubMed ID: 11796748
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Protective effect of metformin against rotenone-induced parkinsonism in mice.
    Wang DX; Chen AD; Wang QJ; Xin YY; Yin J; Jing YH
    Toxicol Mech Methods; 2020 Jun; 30(5):350-357. PubMed ID: 32189544
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The rotenone model of parkinsonism--the five years inspection.
    Höglinger GU; Oertel WH; Hirsch EC
    J Neural Transm Suppl; 2006; (70):269-72. PubMed ID: 17017540
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A dual inhibitor targeting HMG-CoA reductase and histone deacetylase mitigates neurite degeneration in
    Lin CH; Lin HY; Fang JM; Chen CC
    Aging (Albany NY); 2020 Nov; 12(24):25581-25598. PubMed ID: 33231564
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat.
    Khan S; Jena GB
    Chem Biol Interact; 2014 Apr; 213():1-12. PubMed ID: 24530320
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacological validation of TDO as a target for Parkinson's disease.
    Perez-Pardo P; Grobben Y; Willemsen-Seegers N; Hartog M; Tutone M; Muller M; Adolfs Y; Pasterkamp RJ; Vu-Pham D; van Doornmalen AM; van Cauter F; de Wit J; Gerard Sterrenburg J; Uitdehaag JCM; de Man J; Buijsman RC; Zaman GJR; Kraneveld AD
    FEBS J; 2021 Jul; 288(14):4311-4331. PubMed ID: 33471408
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone.
    Inden M; Kitamura Y; Takeuchi H; Yanagida T; Takata K; Kobayashi Y; Taniguchi T; Yoshimoto K; Kaneko M; Okuma Y; Taira T; Ariga H; Shimohama S
    J Neurochem; 2007 Jun; 101(6):1491-1504. PubMed ID: 17459145
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson's disease.
    Barone MC; Sykiotis GP; Bohmann D
    Dis Model Mech; 2011 Sep; 4(5):701-7. PubMed ID: 21719443
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.
    Xiong N; Long X; Xiong J; Jia M; Chen C; Huang J; Ghoorah D; Kong X; Lin Z; Wang T
    Crit Rev Toxicol; 2012 Aug; 42(7):613-32. PubMed ID: 22574684
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ginseng protein protects against mitochondrial dysfunction and neurodegeneration by inducing mitochondrial unfolded protein response in Drosophila melanogaster PINK1 model of Parkinson's disease.
    Liu M; Yu S; Wang J; Qiao J; Liu Y; Wang S; Zhao Y
    J Ethnopharmacol; 2020 Jan; 247():112213. PubMed ID: 31562951
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease.
    Bretaud S; Lee S; Guo S
    Neurotoxicol Teratol; 2004; 26(6):857-64. PubMed ID: 15451049
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sodium Butyrate Controls Cardiac Hypertrophy in Experimental Models of Rats.
    Patel BM
    Cardiovasc Toxicol; 2018 Feb; 18(1):1-8. PubMed ID: 28389765
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Adult health and transition stage-specific rotenone-mediated
    Ayajuddin M; Phom L; Koza Z; Modi P; Das A; Chaurasia R; Thepa A; Jamir N; Neikha K; Yenisetti SC
    Front Mol Neurosci; 2022; 15():896183. PubMed ID: 36017079
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Transferrin1 modulates rotenone-induced Parkinson's disease through affecting iron homeostasis in Drosophila melanogaster.
    Xue J; Wang HL; Xiao G
    Biochem Biophys Res Commun; 2020 Oct; 531(3):305-311. PubMed ID: 32800558
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Parkinson's disease-like motor and non-motor symptoms in rotenone-treated zebrafish.
    Wang Y; Liu W; Yang J; Wang F; Sima Y; Zhong ZM; Wang H; Hu LF; Liu CF
    Neurotoxicology; 2017 Jan; 58():103-109. PubMed ID: 27866991
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronic systemic pesticide exposure reproduces features of Parkinson's disease.
    Betarbet R; Sherer TB; MacKenzie G; Garcia-Osuna M; Panov AV; Greenamyre JT
    Nat Neurosci; 2000 Dec; 3(12):1301-6. PubMed ID: 11100151
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mechanism of toxicity in rotenone models of Parkinson's disease.
    Sherer TB; Betarbet R; Testa CM; Seo BB; Richardson JR; Kim JH; Miller GW; Yagi T; Matsuno-Yagi A; Greenamyre JT
    J Neurosci; 2003 Nov; 23(34):10756-64. PubMed ID: 14645467
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Piperine induces autophagy by enhancing protein phosphotase 2A activity in a rotenone-induced Parkinson's disease model.
    Liu J; Chen M; Wang X; Wang Y; Duan C; Gao G; Lu L; Wu X; Wang X; Yang H
    Oncotarget; 2016 Sep; 7(38):60823-60843. PubMed ID: 27572322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.